Answers are grounded in this paper and cite their sources.
Marrow grafting, originally considered only for end-stage patients after failure of all other treatment, is now the treatment of choice for a variety of malignant and nonmalignant diseases. Donor and recipient selection and the results of marrow transplantation for various diseases and stages of diseases are summarized.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (1984) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: